TickerFactsScreenerDevelopers

BIOMARIN PHARMACEUTICAL INC (BMRN) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2008: $52.51M2009: $65.91M2010: $70.28M2011: $84.02M2012: $91.83M2013: $88.39M2014: $122.27M2015: $152.01M2016: $209.62M2017: $241.79M2018: $315.26M2019: $359.47M2020: $524.27M2021: $470.51M2022: $503.02M2023: $532.06M2024: $580.24M2025: $717.44M$717.44M
2008Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$717.44M+23.6%
2024$580.24M+9.1%
2023$532.06M+5.8%
2022$503.02M+6.9%
2021$470.51M-10.3%
2020$524.27M+45.8%
2019$359.47M+14.0%
2018$315.26M+30.4%
2017$241.79M+15.3%
2016$209.62M+37.9%
2015$152.01M+24.3%
2014$122.27M+38.3%
2013$88.39M-3.7%
2012$91.83M+9.3%
2011$84.02M+19.5%
2010$70.28M+6.6%
2009$65.91M+25.5%
2008$52.51M—